323 related articles for article (PubMed ID: 32782768)
41. JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
Aynardi J; Manur R; Hess PR; Chekol S; Morrissette JJD; Babushok D; Hexner E; Rogers HJ; Hsi ED; Margolskee E; Orazi A; Hasserjian R; Bagg A
Br J Haematol; 2018 Jul; 182(1):78-85. PubMed ID: 29767839
[TBL] [Abstract][Full Text] [Related]
42. Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.
Wang S; Yan J; Zhou G; Heintzelman R; Hou JS
Case Rep Hematol; 2016; 2016():6054017. PubMed ID: 27752371
[TBL] [Abstract][Full Text] [Related]
43. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract][Full Text] [Related]
44. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Kanagal-Shamanna R; Orazi A; Hasserjian RP; Arber DA; Reichard K; Hsi ED; Bagg A; Rogers HJ; Geyer J; Darbaniyan F; Do KA; Devins KM; Pozdnyakova O; George TI; Cin PD; Greipp PT; Routbort MJ; Patel K; Garcia-Manero G; Verstovsek S; Medeiros LJ; Wang SA; Bueso-Ramos C
Mod Pathol; 2022 Apr; 35(4):470-479. PubMed ID: 34775472
[TBL] [Abstract][Full Text] [Related]
45. ASXL1 mutations in Chinese patients with essential thrombocythemia.
Nie YB; Sun M; He CK; Ju MK; Zhou FL; Wu SY; Zhou Y; Liu L; Shen H; Huang TT; Liu P; Xu Y; Shao L; Zuo XL
Exp Ther Med; 2018 May; 15(5):4149-4156. PubMed ID: 29725364
[TBL] [Abstract][Full Text] [Related]
46. Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms.
Singdong R; Siriboonpiputtana T; Chareonsirisuthigul T; Kongruang A; Limsuwanachot N; Sirirat T; Chuncharunee S; Rerkamnuaychoke B
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4647-4653. PubMed ID: 27892678
[TBL] [Abstract][Full Text] [Related]
47. Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms.
Frawley T; O'Brien CP; Conneally E; Vandenberghe E; Percy M; Langabeer SE; Haslam K
Genet Test Mol Biomarkers; 2018 Feb; 22(2):98-103. PubMed ID: 29323541
[TBL] [Abstract][Full Text] [Related]
48. Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms.
Gerke MB; Christodoulou I; Karantanos T
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568631
[TBL] [Abstract][Full Text] [Related]
49. Myelodysplastic/myeloproliferative neoplasms.
Hyjek E; Vardiman JW
Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
[TBL] [Abstract][Full Text] [Related]
50. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract][Full Text] [Related]
51. JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases.
Yang YN; Qin YW; Wang C
Oncol Lett; 2014 Aug; 8(2):841-844. PubMed ID: 25013507
[TBL] [Abstract][Full Text] [Related]
52. Emergence of
Lorenzo M; Grille S; Stevenazzi M
J Hematol; 2020 Apr; 9(1-2):23-29. PubMed ID: 32362982
[TBL] [Abstract][Full Text] [Related]
53. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
54. Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Ferreira Cristina S; Polo B; Lacerda JF
Semin Hematol; 2018 Oct; 55(4):215-222. PubMed ID: 30502850
[TBL] [Abstract][Full Text] [Related]
55. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D; Ramazzotti D; Aroldi A; Redaelli S; Magistroni V; Pirola A; Niro A; Massimino L; Mastini C; Brambilla V; Bombelli S; Bungaro S; Morotti A; Rea D; Stagno F; Martino B; Campiotti L; Caocci G; Usala E; Merli M; Onida F; Bregni M; Elli EM; Fumagalli M; Ciceri F; Perego RA; Pagni F; Mologni L; Piazza R; Gambacorti-Passerini C
Hemasphere; 2020 Dec; 4(6):e497. PubMed ID: 33196013
[TBL] [Abstract][Full Text] [Related]
56. Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Lewandowski K; Gniot M; Wojtaszewska M; Kanduła Z; Becht R; Paczkowska E; Mędraś E; Wasilewska E; Iwoła M
Int J Lab Hematol; 2018 Jun; 40(3):366-371. PubMed ID: 29508552
[TBL] [Abstract][Full Text] [Related]
57. Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms.
Hochman MJ; Savani BN; Jain T
EJHaem; 2021 Aug; 2(3):607-615. PubMed ID: 35844680
[TBL] [Abstract][Full Text] [Related]
58. Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
[TBL] [Abstract][Full Text] [Related]
59. 2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications.
Michiels JJ; Tevet M; Trifa A; Niculescu-Mizil E; Lupu A; Vladareanu AM; Bumbea H; Ilea A; Dobrea C; Georgescu D; Patrinoiu O; Popescu M; Murat M; Dragan C; Mihai F; Zurac S; Angelescu S; Iova A; Popa A; Gogulescu R; Popov V
Maedica (Bucur); 2016 Mar; 11(1):5-25. PubMed ID: 28465746
[TBL] [Abstract][Full Text] [Related]
60. An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor
Borsellino B; Savi A; Pascale MR; Meddi E; Del Principe MI; Cristiano A; Ottone T; Rapanotti MC; Divona M; Travaglini S; Attardi E; Palmieri R; Buzzatti E; Buccisano F; Voso MT
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022058. PubMed ID: 35865394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
